News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Prolysis Limited Release: Commercial Collaboration With Essential Science Limited


10/19/2005 5:09:00 PM

Prolysis Ltd, a private company focused on the discovery and development of novel antibiotic therapies, and Essential Science Ltd, the technology exploitation company, today announced the establishment of a collaboration focused on the commercialisation of Prolysis’ novel bacterial cell biology expertise. The agreement will concentrate on the exploitation of Prolysis’ class-leading antibiotic screening assay technology, which the Company plans to make available on a collaborative basis to interested parties. Essential Science will provide business development support to Prolysis aimed at establishing long-lasting relationships in the areas of library screening, in-licensing of development candidates, out-licensing of Prolysis technologies and development of new applications for Prolysis technology.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES